MLPH fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Molecular Pharmacology (USA) Ltd. engages in the development of pharmaceutical products. It discovers and develops analgesic and anti-inflammatory products based on the proprietary MPL-TL compound. The MPL-TL compound is an oligopeptide which is a new key active ingredient that targets a different part of the pain and inflammation cascade than other analgesic and anti-inflammatory drugs. The company was founded on May 1, 2002 and is headquartered in Stroudsburg, PA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
MLPH does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company